Madrigal Pharmaceuticals, Inc.
(NASDAQ : SNTA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOThe Medicines Co.
0.37%84.2120.1%$585.94m
AMRNAmarin Corp. Plc
2.93%22.451.7%$318.11m
VRXValeant Pharmaceuticals International, Inc.
0.52%29.1014.1%$171.23m
BHCBausch Health Cos., Inc.
0.52%29.100.0%$100.43m
JAZZJazz Pharmaceuticals Plc
0.92%149.462.3%$94.15m
SAGESAGE Therapeutics, Inc.
7.11%64.468.6%$93.27m
GWPHGW Pharmaceuticals Plc
-2.39%101.056.2%$88.36m
ICPTIntercept Pharmaceuticals, Inc.
-10.27%107.4816.9%$82.62m
PRGOPerrigo Co. Plc
0.97%52.316.8%$66.45m
AXSMAxsome Therapeutics, Inc.
5.07%45.432.0%$55.58m
HZNPHorizon Therapeutics Plc
1.16%32.236.6%$43.62m
ICLRICON plc
0.93%162.904.2%$42.90m
ENDPEndo International Plc
0.42%4.848.8%$34.41m
UTHRUnited Therapeutics Corp.
1.53%91.6114.3%$33.37m
MYOKMyoKardia, Inc.
0.46%67.432.1%$30.25m

Company Profile

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.